Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CDJ9292on Jun 07, 2017 9:33am
200 Views
Post# 26334422

RE:RE:RE:At what point...

RE:RE:RE:At what point...
eric40 wrote: Prometic had a rolling BLA where the FDA Staff help them fill the different module of the BLA.

This mean that once the  last module of the BLA was submitted on april 5, the BLA was completed and NO ADDITIONAL INFORMATION will be require.

Also, since the election of Trump, a new FDA director was appoited. Dr. Scott Gottlieb was sworn in as the 23rd Commissioner of Food and Drugs on May 11, 2017.

This is right in the middle of the 60 day period since Prometic finalise the BLA.

M. Gottlieb was already a director at the FDA. I believe, IMO that there is a lot of seats that are changing right now and that it might create some short term delays.





you guys have an answer for everything, and by answer I mean excuse. At what point do you accept that Pierre constantly over promises and under delivers? It's honestly sad watching you grasp at every little possibility as to why we didn't hear something by June 5th. I think it's pretty obvious THERE IS NO PRIORITY REVIEW. You guys blasted this board with FDA articles that clearly stated the FDA has 60 days to respond. It's gone from comical to plain sad listening to you guys make excuses for PL poor management. Stop blaming the FDA, stop counting work days and holidays, stop making up fictitious reasons as to why Fred is out of the office and just accept that facts. Pierre Laurin is a brutal CEO. He does make it super easy to exploite this company though. Took me some time to figure this out but has been much easier making money once I did. Next stop $1.50-$1.75. 

Bullboard Posts